Flexible access to clean, high-quality data and effective risk management are more vital than ever to the success of clinical drug trials. The Remarque Quality Management System is the first that allows sponsors and CROs of all sizes to implement risk-based monitoring (RBM) methodology at scale. In this video, Mike Arlotto, founder of Remarque Systems, discusses how the platform can improve trial execution from the study level. With the Remarque QMS Statistical Monitor Module, you can:
- Focus on one data point or look at every site visit.
- Customize how you view and share the data.
- Use Remarque’s built-in statistical models to quickly identify key study integrity risks.